LXRX vs CRIS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

LXRX

53.1
AI Score
VS
LXRX Wins

CRIS

49.6
AI Score

Investment Advisor Scores

LXRX

53score
Recommendation
HOLD

CRIS

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LXRX CRIS Winner
Forward P/E 0 0 Tie
PEG Ratio -0.14 0 Tie
Revenue Growth 1572.1% -66.0% LXRX
Earnings Growth -63.4% 0.0% CRIS
Tradestie Score 53.1/100 49.6/100 LXRX
Profit Margin -37.5% -299.7% LXRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LXRX 1M: +0.4% · 3M: +42.9% CRIS 1M: +1385.9% · 3M: +769.9%

Current Technical Phase

LXRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.3% over 20 days), RSI 55

RSI (14): 54.6 · Price: $2.33

CRIS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (288.9% over 20 days), RSI 70

RSI (14): 70.0 · Price: $5.15

Fundamentals Snapshot

Metric LXRX CRIS
Market Cap
Forward P/E -11.3 -0.3
Trailing P/E
Revenue (TTM)
Revenue Growth 15.7% -0.7%
Gross Margin 0.9% -2.7%
Operating Margin 0.0% -4.9%
EPS -0.07 -11.76
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.